Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Cytokinetics CYTK Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.3M	Hold	660,310	–	–	3.08%	14
2026 Q1	$43.5M	Sell	660,310 -87,673	-12%	-$5.57M	3.69%	8
2025 Q4	$47.5M	Sell	747,983 -444,501	-37%	-$27.7M	4.22%	8
2025 Q3	$65.5M	Buy	1,192,484 +109,921	+10%	+$4.53M	5.06%	6
2025 Q2	$35.8M	Buy	1,082,563 +921,278	+571%	+$32M	4.23%	9
2025 Q1	$6.48M	Sell	161,285 -167,851	-51%	-$7.71M	1.34%	23
2024 Q4	$15.5M	Buy	+329,136	New	+$17.1M	1.87%	25
2024 Q2	–	Sell	-461,018	Closed	-$32.3M	–	42
2024 Q1	$32.3M	Buy	461,018 +116,534	+34%	+$9.01M	4.98%	8
2023 Q4	$28.8M	Buy	+344,484	New	+$12.5M	6.55%	3

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's CYTK Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held its Cytokinetics (CYTK) position steady in Q2 2026 at 660,310 shares worth $56.3M. The position accounts for 3.08% of the portfolio, ranked #14.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in CYTK in Q4 2023 and has held it in 9 quarters since. The position peaked at $65.5M in Q3 2025. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held 660,310 shares of Cytokinetics worth $56.3M as of Q2 2026.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne left its Cytokinetics share count unchanged in Q2 2026.
Cytokinetics made up 3.08% of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's portfolio in Q2 2026, its #14 holding.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Cytokinetics in Q4 2023 and has held it in 9 quarters since.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Cytokinetics position peaked at $65.5M in Q3 2025.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.